US Stock MarketDetailed Quotes

GALT Galectin Therapeutics

Watchlist
  • 2.835
  • +0.065+2.35%
Close Nov 27 16:00 ET
  • 2.920
  • +0.085+3.00%
Post 20:01 ET
177.93MMarket Cap-3883P/E (TTM)

Galectin Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.80%-8.54M
15.25%-8.33M
-12.16%-12.11M
-6.15%-32.97M
35.05%-4.7M
8.51%-7.64M
-32.38%-9.83M
-34.21%-10.79M
-27.76%-31.06M
-4.14%-7.24M
Net income from continuing operations
-7.59%-11.22M
-35.74%-12.37M
0.33%-11.49M
-5.91%-41.07M
5.99%-10M
-21.30%-10.43M
5.19%-9.11M
-16.06%-11.53M
-27.02%-38.78M
-47.26%-10.63M
Operating gains losses
53.88%754K
77.96%-108K
12.87%868K
177.56%432K
-21.66%-337K
118.75%490K
-78.18%-490K
435.81%769K
-303.62%-557K
41.81%-277K
Depreciation and amortization
12.50%9K
156.25%9K
-71.88%9K
3.13%33K
12.50%9K
14.29%8K
-328.57%-16K
220.00%32K
-21.95%32K
-27.27%8K
Other non cash items
51.56%291K
47.34%249K
44.44%208K
70.00%697K
43.28%192K
62.71%192K
116.67%169K
80.00%144K
44.88%410K
-18.79%134K
Change In working capital
-26.53%1.11M
450.78%3.15M
-164.03%-2.31M
-5.84%4.68M
73.18%4.93M
294.23%1.52M
-151.97%-898K
-174.55%-873K
25.55%4.97M
3,491.67%2.85M
-Change in prepaid assets
-67.19%83K
-21.45%216K
-20.77%145K
-189.11%-90K
-19.37%-801K
-20.44%253K
-6.46%275K
14.38%183K
55.38%101K
21.98%-671K
-Change in payables and accrued expense
-18.38%1.03M
350.13%2.93M
-132.01%-2.45M
-2.03%4.77M
62.93%5.74M
214.94%1.26M
-181.80%-1.17M
-204.45%-1.06M
25.05%4.87M
353.61%3.52M
Cash from discontinued investing activities
Operating cash flow
-11.80%-8.54M
15.25%-8.33M
-12.16%-12.11M
-6.15%-32.97M
35.05%-4.7M
8.51%-7.64M
-32.38%-9.83M
-34.21%-10.79M
-27.76%-31.06M
-4.14%-7.24M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
----
----
----
----
--0
----
Financing cash flow
Cash flow from continuing financing activities
-0.33%10M
3.76%10.38M
0.00%10M
300.33%40.03M
0.00%10M
10.03M
10M
10M
-72.84%10M
0.01%10M
Net issuance payments of debt
--10M
0.00%10M
0.00%10M
200.00%30M
0.00%10M
--0
--10M
--10M
-66.67%10M
0.00%10M
Proceeds from stock option exercised by employees
--0
----
----
--10.03M
--0
----
----
----
--0
--0
Cash from discontinued financing activities
Financing cash flow
-0.33%10M
3.76%10.38M
0.00%10M
300.33%40.03M
0.00%10M
--10.03M
--10M
--10M
-72.84%10M
0.01%10M
Net cash flow
Beginning cash position
42.48%25.6M
30.87%23.56M
38.02%25.66M
-53.11%18.59M
28.62%20.36M
-25.69%17.97M
-43.05%18M
-53.11%18.59M
46.08%39.65M
-56.75%15.83M
Current changes in cash
-38.98%1.46M
6,290.91%2.04M
-254.97%-2.11M
133.57%7.07M
91.89%5.3M
128.70%2.4M
99.56%-33K
92.63%-593K
-268.37%-21.06M
-9.42%2.76M
End cash Position
32.89%27.06M
42.48%25.6M
30.87%23.56M
38.02%25.66M
38.02%25.66M
28.62%20.36M
-25.69%17.97M
-43.05%18M
-53.11%18.59M
-53.11%18.59M
Free cash flow
-11.80%-8.54M
15.25%-8.33M
-12.16%-12.11M
-6.15%-32.97M
35.05%-4.7M
8.51%-7.64M
-32.38%-9.83M
-34.21%-10.79M
-27.76%-31.06M
-4.14%-7.24M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.80%-8.54M15.25%-8.33M-12.16%-12.11M-6.15%-32.97M35.05%-4.7M8.51%-7.64M-32.38%-9.83M-34.21%-10.79M-27.76%-31.06M-4.14%-7.24M
Net income from continuing operations -7.59%-11.22M-35.74%-12.37M0.33%-11.49M-5.91%-41.07M5.99%-10M-21.30%-10.43M5.19%-9.11M-16.06%-11.53M-27.02%-38.78M-47.26%-10.63M
Operating gains losses 53.88%754K77.96%-108K12.87%868K177.56%432K-21.66%-337K118.75%490K-78.18%-490K435.81%769K-303.62%-557K41.81%-277K
Depreciation and amortization 12.50%9K156.25%9K-71.88%9K3.13%33K12.50%9K14.29%8K-328.57%-16K220.00%32K-21.95%32K-27.27%8K
Other non cash items 51.56%291K47.34%249K44.44%208K70.00%697K43.28%192K62.71%192K116.67%169K80.00%144K44.88%410K-18.79%134K
Change In working capital -26.53%1.11M450.78%3.15M-164.03%-2.31M-5.84%4.68M73.18%4.93M294.23%1.52M-151.97%-898K-174.55%-873K25.55%4.97M3,491.67%2.85M
-Change in prepaid assets -67.19%83K-21.45%216K-20.77%145K-189.11%-90K-19.37%-801K-20.44%253K-6.46%275K14.38%183K55.38%101K21.98%-671K
-Change in payables and accrued expense -18.38%1.03M350.13%2.93M-132.01%-2.45M-2.03%4.77M62.93%5.74M214.94%1.26M-181.80%-1.17M-204.45%-1.06M25.05%4.87M353.61%3.52M
Cash from discontinued investing activities
Operating cash flow -11.80%-8.54M15.25%-8.33M-12.16%-12.11M-6.15%-32.97M35.05%-4.7M8.51%-7.64M-32.38%-9.83M-34.21%-10.79M-27.76%-31.06M-4.14%-7.24M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --------------0------------------0----
Financing cash flow
Cash flow from continuing financing activities -0.33%10M3.76%10.38M0.00%10M300.33%40.03M0.00%10M10.03M10M10M-72.84%10M0.01%10M
Net issuance payments of debt --10M0.00%10M0.00%10M200.00%30M0.00%10M--0--10M--10M-66.67%10M0.00%10M
Proceeds from stock option exercised by employees --0----------10.03M--0--------------0--0
Cash from discontinued financing activities
Financing cash flow -0.33%10M3.76%10.38M0.00%10M300.33%40.03M0.00%10M--10.03M--10M--10M-72.84%10M0.01%10M
Net cash flow
Beginning cash position 42.48%25.6M30.87%23.56M38.02%25.66M-53.11%18.59M28.62%20.36M-25.69%17.97M-43.05%18M-53.11%18.59M46.08%39.65M-56.75%15.83M
Current changes in cash -38.98%1.46M6,290.91%2.04M-254.97%-2.11M133.57%7.07M91.89%5.3M128.70%2.4M99.56%-33K92.63%-593K-268.37%-21.06M-9.42%2.76M
End cash Position 32.89%27.06M42.48%25.6M30.87%23.56M38.02%25.66M38.02%25.66M28.62%20.36M-25.69%17.97M-43.05%18M-53.11%18.59M-53.11%18.59M
Free cash flow -11.80%-8.54M15.25%-8.33M-12.16%-12.11M-6.15%-32.97M35.05%-4.7M8.51%-7.64M-32.38%-9.83M-34.21%-10.79M-27.76%-31.06M-4.14%-7.24M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data